18 September 2018 - ‘Each application would be assessed on its own merits,’ senators told.

Pharmaceutical companies will be allowed to apply for data from the controversial My Health Record system, a Senate committee hearing has been told.

Caroline Edwards, the deputy secretary of the Department of Health, told the committee third-party access arrangements would allow medical and public health researchers access to de-identified data.

Read The Guardian article